3-(4-Chloro-phenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadazin-6-yl-acetic acid ethyl ester is a chemical compound characterized by its complex heterocyclic structure, which includes a triazole and thiadiazine moiety. This compound typically exhibits properties such as moderate solubility in organic solvents and potential bioactivity, making it of interest in pharmaceutical research. The presence of the chloro-substituent on the phenyl ring may influence its reactivity and interaction with biological targets. Ethyl ester functionality suggests that it may undergo hydrolysis to release the corresponding acid, which can be relevant in metabolic studies. The compound's unique structure may contribute to its potential applications in medicinal chemistry, particularly in the development of new therapeutic agents. As with many heterocyclic compounds, its synthesis and characterization would involve various analytical techniques, including NMR, mass spectrometry, and possibly X-ray crystallography, to confirm its identity and purity. Safety and handling precautions should be observed due to the presence of halogenated and nitrogen-containing groups.

3-(4-CHLORO-PHENYL)-7H-[1,2,4]TRIAZOLO[3,4-B][1,3,4]THIADIAZIN-6-YL]-ACETIC ACID ETHYL ESTER

150536-08-6: 3-(4-Chloro-phenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadazin-6-yl-acetic acid ethyl ester is a chemical compound characterized by its complex heterocyclic structure, which includes a triazole and thiadiazine moiety. This compound typically exhibits properties such as moderate solubility in organic solvents and potential bioactivity, making it of interest in pharmaceutical research. The presence of the chloro-substituent on the phenyl ring may influence its reactivity and interaction with biological targets. Ethyl ester functionality suggests that it may undergo hydrolysis to release the corresponding acid, which can be relevant in metabolic studies. The compound's unique structure may contribute to its potential applications in medicinal chemistry, particularly in the development of new therapeutic agents. As with many heterocyclic compounds, its synthesis and characterization would involve various analytical techniques, including NMR, mass spectrometry, and possibly X-ray crystallography, to confirm its identity and purity. Safety and handling precautions should be observed due to the presence of halogenated and nitrogen-containing groups.

CAS 150536-08-6

3-(4-CHLORO-PHENYL)-7H-[1,2,4]TRIAZOLO[3,4-B][1,3,4]THIADIAZIN-6-YL]-ACETIC ACID ETHYL ESTER

Ethyl 2-[3-(4-chlorophenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazin-6-yl]acetate

Ref: 3D-AGA53608